Last reviewed · How we verify
NCT05371171
Management of Skin Graft Donor Site Wound in Aged Patient
NA trial testing skin graft in Skin Regrafting; Donor Site of Skin Grafting; Vancouver Scar Scale in 15 participants. Completed in 3 September 2019.
24 May 2019
Quick facts
| Lead sponsor | Taipei Medical University WanFang Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 13 March 2018 |
| Primary completion | 24 May 2019 |
| Estimated completion | 3 September 2019 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- skin graft
- no skin graft
Conditions studied
- Skin Regrafting; Donor Site of Skin Grafting; Vancouver Scar Scale — all drugs for Skin Regrafting; Donor Site of Skin Grafting; Vancouver Scar Scale →
Sponsor
Taipei Medical University WanFang Hospital
Who can join
Adults 60 Months to 99 Months, any sex, with Skin Regrafting; Donor Site of Skin Grafting; Vancouver Scar Scale. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The complication of donor site in skin grafting often acts as a causing factor for extended treatment period. The elderly individuals tend to be afflicted by impaired wound healing. Herein, the investigators presented the outcome of skin regrafting in the elderly patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05371171
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of skin graft
Trials testing the same drug.
- NCT02070835 — Cellular Reprogramming-Enhanced Skin Grafting for Diabetic Foot Ulcers · NA · completed
- NCT02090361 — Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts · NA · completed
- NCT06182345 — Spray Skin Treats for Pediatric Burns · unknown
Other Taipei Medical University WanFang Hospital trials
Trials by the same sponsor.
- NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
- NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
- NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
- NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
- NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05371171 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
- Last refreshed: 12 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05371171.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing